{"entity":{"type":"insider","cik":"0001283260","url":"/insider/0001283260","json_url":"/insider/0001283260.json","name":"LENZ BRIAN","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":27,"n_filings":22,"first":"2005-12-09","last":"2023-08-17","span_basis":"filed_date"},"name_variants":[{"name":"LENZ BRIAN","source":"filing","n_filings":22,"first_seen":"2005-12-09","last_seen":"2023-08-17"}],"transactions":[{"id":7966091,"accession":"0001140361-23-040321","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001140361-23-040321","line_url":"/filing/0001140361-23-040321#line-9","is_derivative":false,"issuer_cik":"0001283260","issuer_name":"ADMA BIOLOGICS, INC.","issuer_ticker":"ADMA","issuer_name_source":null,"issuer_url":"/issuer/0001283260","owner_cik":"0001283260","owner_name":"LENZ BRIAN","owner_display_name":"LENZ BRIAN","owner_url":"/insider/0001283260","role":"Officer (EVP, CFO)","role_mark":"O","role_mark_label":"Officer (EVP, CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":178184.0,"shares_display":"178,184","price_per_share":4.4527,"price_display":"4.45","price_state":"stated","total_value":793399.8968,"total_display":"793,399.90","total_whole":"793,400","shares_owned_after":782013.0,"shares_owned_after_display":"782,013","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-16","filed_date":"2023-08-17","scope":"insider"},{"id":7966089,"accession":"0001140361-23-040321","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001140361-23-040321","line_url":"/filing/0001140361-23-040321#line-8","is_derivative":false,"issuer_cik":"0001283260","issuer_name":"ADMA BIOLOGICS, INC.","issuer_ticker":"ADMA","issuer_name_source":null,"issuer_url":"/issuer/0001283260","owner_cik":"0001283260","owner_name":"LENZ BRIAN","owner_display_name":"LENZ BRIAN","owner_url":"/insider/0001283260","role":"Officer (EVP, CFO)","role_mark":"O","role_mark_label":"Officer (EVP, CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":211578.0,"shares_display":"211,578","price_per_share":4.5975,"price_display":"4.60","price_state":"stated","total_value":972729.855,"total_display":"972,729.86","total_whole":"972,730","shares_owned_after":782013.0,"shares_owned_after_display":"782,013","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-15","filed_date":"2023-08-17","scope":"insider"},{"id":6506839,"accession":"0001140361-22-045112","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-22-045112","line_url":"/filing/0001140361-22-045112#line-1","is_derivative":false,"issuer_cik":"0001283260","issuer_name":"ADMA BIOLOGICS, INC.","issuer_ticker":"ADMA","issuer_name_source":null,"issuer_url":"/issuer/0001283260","owner_cik":"0001283260","owner_name":"LENZ BRIAN","owner_display_name":"LENZ BRIAN","owner_url":"/insider/0001283260","role":"Officer (EVP, CFO)","role_mark":"O","role_mark_label":"Officer (EVP, CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6993.0,"shares_display":"6,993","price_per_share":2.86,"price_display":"2.86","price_state":"stated","total_value":19999.98,"total_display":"19,999.98","total_whole":"20,000","shares_owned_after":1034825.0,"shares_owned_after_display":"1,034,825","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-09","filed_date":"2022-12-09","scope":"insider"},{"id":4963185,"accession":"0001140361-21-035380","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-21-035380","line_url":"/filing/0001140361-21-035380#line-1","is_derivative":false,"issuer_cik":"0001283260","issuer_name":"ADMA BIOLOGICS, INC.","issuer_ticker":"ADMA","issuer_name_source":null,"issuer_url":"/issuer/0001283260","owner_cik":"0001283260","owner_name":"LENZ BRIAN","owner_display_name":"LENZ BRIAN","owner_url":"/insider/0001283260","role":"Officer (EVP, CFO)","role_mark":"O","role_mark_label":"Officer (EVP, CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":1.0,"price_display":"1.00","price_state":"stated","total_value":30000.0,"total_display":"30,000.00","total_whole":"30,000","shares_owned_after":1065501.0,"shares_owned_after_display":"1,065,501","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-25","filed_date":"2021-10-26","scope":"insider"},{"id":2065373,"accession":"0001193805-20-001004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-20-001004","line_url":"/filing/0001193805-20-001004#line-1","is_derivative":false,"issuer_cik":"0001283260","issuer_name":"ADMA BIOLOGICS, INC.","issuer_ticker":"ADMA","issuer_name_source":null,"issuer_url":"/issuer/0001283260","owner_cik":"0001283260","owner_name":"LENZ BRIAN","owner_display_name":"LENZ BRIAN","owner_url":"/insider/0001283260","role":"Officer (EVP, CFO)","role_mark":"O","role_mark_label":"Officer (EVP, CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":2.965,"price_display":"2.96","price_state":"stated","total_value":11860.0,"total_display":"11,860.00","total_whole":"11,860","shares_owned_after":76142.0,"shares_owned_after_display":"76,142","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-11","filed_date":"2020-08-12","scope":"insider"},{"id":3337497,"accession":"0001193805-20-000129","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-20-000129","line_url":"/filing/0001193805-20-000129#line-1","is_derivative":false,"issuer_cik":"0001283260","issuer_name":"ADMA BIOLOGICS, INC.","issuer_ticker":"ADMA","issuer_name_source":null,"issuer_url":"/issuer/0001283260","owner_cik":"0001283260","owner_name":"LENZ BRIAN","owner_display_name":"LENZ BRIAN","owner_url":"/insider/0001283260","role":"Officer (EVP, CFO)","role_mark":"O","role_mark_label":"Officer (EVP, CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7142.0,"shares_display":"7,142","price_per_share":3.5,"price_display":"3.50","price_state":"stated","total_value":24997.0,"total_display":"24,997.00","total_whole":"24,997","shares_owned_after":32142.0,"shares_owned_after_display":"32,142","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-11","filed_date":"2020-02-11","scope":"insider"},{"id":7874288,"accession":"0001193805-19-000521","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-19-000521","line_url":"/filing/0001193805-19-000521#line-1","is_derivative":false,"issuer_cik":"0001283260","issuer_name":"ADMA BIOLOGICS, INC.","issuer_ticker":"ADMA","issuer_name_source":null,"issuer_url":"/issuer/0001283260","owner_cik":"0001283260","owner_name":"LENZ BRIAN","owner_display_name":"LENZ BRIAN","owner_url":"/insider/0001283260","role":"Officer (EVP, CFO)","role_mark":"O","role_mark_label":"Officer (EVP, CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":20000.0,"total_display":"20,000.00","total_whole":"20,000","shares_owned_after":25000.0,"shares_owned_after_display":"25,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-17","filed_date":"2019-05-21","scope":"insider"},{"id":6038411,"accession":"0001193805-18-000818","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-18-000818","line_url":"/filing/0001193805-18-000818#line-1","is_derivative":false,"issuer_cik":"0001283260","issuer_name":"ADMA BIOLOGICS, INC.","issuer_ticker":"ADMA","issuer_name_source":null,"issuer_url":"/issuer/0001283260","owner_cik":"0001283260","owner_name":"LENZ BRIAN","owner_display_name":"LENZ BRIAN","owner_url":"/insider/0001283260","role":"Officer (VP, CFO)","role_mark":"O","role_mark_label":"Officer (VP, CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":4.78,"price_display":"4.78","price_state":"stated","total_value":23900.0,"total_display":"23,900.00","total_whole":"23,900","shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-08","filed_date":"2018-06-11","scope":"insider"},{"id":5277606,"accession":"0001193805-17-003453","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-17-003453","line_url":"/filing/0001193805-17-003453#line-1","is_derivative":false,"issuer_cik":"0001283260","issuer_name":"ADMA BIOLOGICS, INC.","issuer_ticker":"ADMA","issuer_name_source":null,"issuer_url":"/issuer/0001283260","owner_cik":"0001283260","owner_name":"LENZ BRIAN","owner_display_name":"LENZ BRIAN","owner_url":"/insider/0001283260","role":"Officer (VP, CFO)","role_mark":"O","role_mark_label":"Officer (VP, CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6500.0,"shares_display":"6,500","price_per_share":2.15,"price_display":"2.15","price_state":"stated","total_value":13975.0,"total_display":"13,975.00","total_whole":"13,975","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-09","filed_date":"2017-11-13","scope":"insider"},{"id":2583179,"accession":"0001193805-16-003192","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-16-003192","line_url":"/filing/0001193805-16-003192#line-1","is_derivative":false,"issuer_cik":"0001283260","issuer_name":"ADMA BIOLOGICS, INC.","issuer_ticker":"ADMA","issuer_name_source":null,"issuer_url":"/issuer/0001283260","owner_cik":"0001283260","owner_name":"LENZ BRIAN","owner_display_name":"LENZ BRIAN","owner_url":"/insider/0001283260","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":6.5,"price_display":"6.50","price_state":"stated","total_value":16250.0,"total_display":"16,250.00","total_whole":"16,250","shares_owned_after":8500.0,"shares_owned_after_display":"8,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-03","filed_date":"2016-05-05","scope":"insider"},{"id":8792064,"accession":"0001193805-15-001978","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193805-15-001978","line_url":"/filing/0001193805-15-001978","is_derivative":false,"issuer_cik":"0001283260","issuer_name":"ADMA BIOLOGICS, INC.","issuer_ticker":"ADMA","issuer_name_source":null,"issuer_url":"/issuer/0001283260","owner_cik":"0001283260","owner_name":"LENZ BRIAN","owner_display_name":"LENZ BRIAN","owner_url":"/insider/0001283260","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":9.150775,"price_display":"9.15","price_state":"stated","total_value":9150.775,"total_display":"9,150.78","total_whole":"9,151","shares_owned_after":6000.0,"shares_owned_after_display":"6,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-02","filed_date":"2015-12-03","scope":"insider","n_lines":3},{"id":8845019,"accession":"0001193805-15-000421","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193805-15-000421","line_url":"/filing/0001193805-15-000421","is_derivative":false,"issuer_cik":"0001283260","issuer_name":"ADMA BIOLOGICS, INC.","issuer_ticker":"ADMA","issuer_name_source":null,"issuer_url":"/issuer/0001283260","owner_cik":"0001283260","owner_name":"LENZ BRIAN","owner_display_name":"LENZ BRIAN","owner_url":"/insider/0001283260","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":750.0,"shares_display":"750","price_per_share":8.952,"price_display":"8.95","price_state":"stated","total_value":6714.0,"total_display":"6,714.00","total_whole":"6,714","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-19","filed_date":"2015-03-23","scope":"insider","n_lines":2},{"id":8932422,"accession":"0001193805-15-000400","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-15-000400","line_url":"/filing/0001193805-15-000400#line-1","is_derivative":false,"issuer_cik":"0001283260","issuer_name":"ADMA BIOLOGICS, INC.","issuer_ticker":"ADMA","issuer_name_source":null,"issuer_url":"/issuer/0001283260","owner_cik":"0001283260","owner_name":"LENZ BRIAN","owner_display_name":"LENZ BRIAN","owner_url":"/insider/0001283260","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1250.0,"shares_display":"1,250","price_per_share":7.969,"price_display":"7.97","price_state":"stated","total_value":9961.25,"total_display":"9,961.25","total_whole":"9,961","shares_owned_after":4250.0,"shares_owned_after_display":"4,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-16","filed_date":"2015-03-18","scope":"insider"},{"id":6185881,"accession":"0001193805-14-001708","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-14-001708","line_url":"/filing/0001193805-14-001708#line-1","is_derivative":false,"issuer_cik":"0001283260","issuer_name":"ADMA BIOLOGICS, INC.","issuer_ticker":"ADMA","issuer_name_source":null,"issuer_url":"/issuer/0001283260","owner_cik":"0001283260","owner_name":"LENZ BRIAN","owner_display_name":"LENZ BRIAN","owner_url":"/insider/0001283260","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":9.8,"price_display":"9.80","price_state":"stated","total_value":4900.0,"total_display":"4,900.00","total_whole":"4,900","shares_owned_after":3000.0,"shares_owned_after_display":"3,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-13","filed_date":"2014-08-15","scope":"insider"},{"id":6554304,"accession":"0001193805-14-001094","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-14-001094","line_url":"/filing/0001193805-14-001094#line-1","is_derivative":false,"issuer_cik":"0001283260","issuer_name":"ADMA BIOLOGICS, INC.","issuer_ticker":"ADMA","issuer_name_source":null,"issuer_url":"/issuer/0001283260","owner_cik":"0001283260","owner_name":"LENZ BRIAN","owner_display_name":"LENZ BRIAN","owner_url":"/insider/0001283260","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":8.06,"price_display":"8.06","price_state":"stated","total_value":4030.0,"total_display":"4,030.00","total_whole":"4,030","shares_owned_after":2500.0,"shares_owned_after_display":"2,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-22","filed_date":"2014-05-27","scope":"insider"},{"id":6554303,"accession":"0001193805-14-001046","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-14-001046","line_url":"/filing/0001193805-14-001046#line-1","is_derivative":false,"issuer_cik":"0001283260","issuer_name":"ADMA BIOLOGICS, INC.","issuer_ticker":"ADMA","issuer_name_source":null,"issuer_url":"/issuer/0001283260","owner_cik":"0001283260","owner_name":"LENZ BRIAN","owner_display_name":"LENZ BRIAN","owner_url":"/insider/0001283260","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":7.5,"price_display":"7.50","price_state":"stated","total_value":7500.0,"total_display":"7,500.00","total_whole":"7,500","shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-14","filed_date":"2014-05-16","scope":"insider"},{"id":5069687,"accession":"0001193805-13-001896","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-13-001896","line_url":"/filing/0001193805-13-001896#line-1","is_derivative":false,"issuer_cik":"0001283260","issuer_name":"ADMA BIOLOGICS, INC.","issuer_ticker":"ADMA","issuer_name_source":null,"issuer_url":"/issuer/0001283260","owner_cik":"0001283260","owner_name":"LENZ BRIAN","owner_display_name":"LENZ BRIAN","owner_url":"/insider/0001283260","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":8.5,"price_display":"8.50","price_state":"stated","total_value":8500.0,"total_display":"8,500.00","total_whole":"8,500","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-10-22","filed_date":"2013-10-23","scope":"insider"},{"id":9077612,"accession":"0001144204-11-069818","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-11-069818","line_url":"/filing/0001144204-11-069818","is_derivative":false,"issuer_cik":"0001283260","issuer_name":"CorMedix Inc.","issuer_ticker":"CRMD","issuer_name_source":null,"issuer_url":"/issuer/0001283260","owner_cik":"0001283260","owner_name":"LENZ BRIAN","owner_display_name":"LENZ BRIAN","owner_url":"/insider/0001283260","role":"Officer (CFO, TREASURER & SECRETARY)","role_mark":"O","role_mark_label":"Officer (CFO, TREASURER & SECRETARY)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO, TREASURER & SECRETARY","security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":14000.0,"shares_display":"14,000","price_per_share":0.3442857142857143,"price_display":"0.34","price_state":"stated","total_value":4820.0,"total_display":"4,820.00","total_whole":"4,820","shares_owned_after":13000.0,"shares_owned_after_display":"13,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-12-14","filed_date":"2011-12-14","scope":"insider","n_lines":2},{"id":7748860,"accession":"0001193805-10-002258","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-10-002258","line_url":"/filing/0001193805-10-002258#line-1","is_derivative":false,"issuer_cik":"0001283260","issuer_name":"CorMedix Inc.","issuer_ticker":"CRMD","issuer_name_source":null,"issuer_url":"/issuer/0001283260","owner_cik":"0001283260","owner_name":"LENZ BRIAN","owner_display_name":"LENZ BRIAN","owner_url":"/insider/0001283260","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":1.54,"price_display":"1.54","price_state":"stated","total_value":1540.0,"total_display":"1,540.00","total_whole":"1,540","shares_owned_after":3000.0,"shares_owned_after_display":"3,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-08-16","filed_date":"2010-08-18","scope":"insider"},{"id":7143303,"accession":"0001193805-10-000947","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-10-000947","line_url":"/filing/0001193805-10-000947#line-1","is_derivative":false,"issuer_cik":"0001283260","issuer_name":"CorMedix Inc.","issuer_ticker":"CRMD","issuer_name_source":null,"issuer_url":"/issuer/0001283260","owner_cik":"0001283260","owner_name":"LENZ BRIAN","owner_display_name":"LENZ BRIAN","owner_url":"/insider/0001283260","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-03-30","filed_date":"2010-04-01","scope":"insider"},{"id":9207429,"accession":"0000914190-08-000683","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914190-08-000683","line_url":"/filing/0000914190-08-000683#line-1","is_derivative":false,"issuer_cik":"0001195116","issuer_name":"Arno Therapeutics, Inc","issuer_ticker":"ARNI","issuer_name_source":null,"issuer_url":"/issuer/0001195116","owner_cik":"0001283260","owner_name":"LENZ BRIAN","owner_display_name":"LENZ BRIAN","owner_url":"/insider/0001283260","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":3.0,"price_display":"3.00","price_state":"stated","total_value":12000.0,"total_display":"12,000.00","total_whole":"12,000","shares_owned_after":4000.0,"shares_owned_after_display":"4,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-08","filed_date":"2008-09-09","scope":"insider"},{"id":3632458,"accession":"0001179110-08-001106","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-08-001106","line_url":"/filing/0001179110-08-001106#line-1","is_derivative":false,"issuer_cik":"0000745788","issuer_name":"VioQuest Pharmaceuticals, Inc.","issuer_ticker":"VQPH","issuer_name_source":null,"issuer_url":"/issuer/0000745788","owner_cik":"0001283260","owner_name":"LENZ BRIAN","owner_display_name":"LENZ BRIAN","owner_url":"/insider/0001283260","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.1208,"price_display":"0.12","price_state":"stated","total_value":1208.0,"total_display":"1,208.00","total_whole":"1,208","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-01-14","filed_date":"2008-01-14","scope":"insider"},{"id":1253588,"accession":"0001179110-05-022692","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-05-022692","line_url":"/filing/0001179110-05-022692#line-1","is_derivative":false,"issuer_cik":"0000745788","issuer_name":"VioQuest Pharmaceuticals, Inc.","issuer_ticker":"VQPH","issuer_name_source":null,"issuer_url":"/issuer/0000745788","owner_cik":"0001283260","owner_name":"LENZ BRIAN","owner_display_name":"LENZ BRIAN","owner_url":"/insider/0001283260","role":"Officer (CFO, Secretary and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO, Secretary and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO, Secretary and Treasurer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.8,"price_display":"0.80","price_state":"stated","total_value":4000.0,"total_display":"4,000.00","total_whole":"4,000","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-12-09","filed_date":"2005-12-09","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":27,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":25,"open_market":true},{"code":"S","label":"Open-market sale","n":2,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":27},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001368514","name":"ADMA BIOLOGICS, INC.","url":"/issuer/0001368514","role":"Officer (EVP, CFO)","n_filings":16,"first_seen":"2013-10-23","last_seen":"2023-08-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001410098","name":"CorMedix Inc.","url":"/issuer/0001410098","role":"Officer (CFO, TREASURER & SECRETARY)","n_filings":3,"first_seen":"2010-04-01","last_seen":"2011-12-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001195116","name":"Arno Therapeutics, Inc","url":"/issuer/0001195116","role":"Officer (Chief Financial Officer)","n_filings":1,"first_seen":"2008-09-09","last_seen":"2008-09-09"},{"type":"issuer","type_label":"ISSUER","cik":"0000745788","name":"VioQuest Pharmaceuticals, Inc.","url":"/issuer/0000745788","role":"Officer (CFO and Treasurer)","n_filings":2,"first_seen":"2005-12-09","last_seen":"2008-01-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001283260","retrieved_at":"2026-08-23T00:35:43+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}